Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Red Signal for AstraZeneca Drug
Yahoo/Zacks.com
Monday, September 6, 2010 - 10:01am
tags:
AstraZeneca, MedImmune, RSV, motavizumab
Report into J&J product recalls looms
FT.com
Monday, September 6, 2010 - 9:59am
tags:
JNJ, recalls
Roche Plans Cutbacks on Pressure From Failures: Biotech's Latest Mishaps
Seeking Alpha
Monday, September 6, 2010 - 9:58am
tags:
Roche, layoffs, Abbott Laboratories, AstraZeneca, Pfizer, Celldex, Ranbaxy, Allergan
History Predicts Genzyme Will Sell For $80 Per Share
Minyanville
Saturday, September 4, 2010 - 1:46pm
tags:
Genzyme, M&A, Sanofi
Docs more receptive to reps at industry confabs
Fierce Pharma
Saturday, September 4, 2010 - 7:30am
tags:
physicians, drug reps, physician access
Novartis Malaria Drug May Yield First New Treatment in 30 Years
Bloomberg
Saturday, September 4, 2010 - 7:28am
tags:
Novartis, malaria
Is King Pharmaceuticals a Cash Machine?
Motley Fool
Saturday, September 4, 2010 - 7:26am
tags:
King
Family Wins Fight Linking MMR Vaccine To Epilepsy
Pharmalot
Friday, September 3, 2010 - 12:13pm
tags:
vaccines, epilepsy, MMR
A Look at Immunogen Beyond the T-DM1 Setback
Seeking Alpha
Friday, September 3, 2010 - 12:11pm
tags:
Immunogen, TDM1
BDSI shares surge on postive Onsolis meeting with FDA
Bizjournals.com
Friday, September 3, 2010 - 12:08pm
tags:
BioDelivery Sciences, Onsolis, FDA
Will Johnson & Johnson's Dividends Last?
Motley Fool
Friday, September 3, 2010 - 12:00pm
tags:
dividends, JNJ
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Friday, September 3, 2010 - 11:57am
tags:
Arena Pharmaceuticals, Contrave, Orexigen, Vivus, obesity, Qnexa
5-Star Stocks Poised to Pop: Gilead Sciences
Motley Fool
Friday, September 3, 2010 - 11:55am
tags:
Gilead Sciences
Celldex, Pfizer Split Over Brain Tumor Drug
TheStreet.com
Friday, September 3, 2010 - 11:54am
tags:
Celldex, Pfizer, brain tumors
Genzyme’s Termeer Could Sell Company
NY Times, NY
Friday, September 3, 2010 - 11:53am
tags:
Henri Termeer, M&A, Sanofi, Genzyme
Are Pharmaceutical Executives Hampering the Ability of their Companies to Change?
Pharmareform
Friday, September 3, 2010 - 10:48am
tags:
pharma execs
Checking for Revenue Tricks at Talecris Biotherapeutics Holdings
Motley Fool
Friday, September 3, 2010 - 10:47am
tags:
Talecris
Abbott Halts Sale of Flu Vaccine Business
NY Times, NY
Friday, September 3, 2010 - 10:46am
tags:
Abbott Laboratories, vaccines, M&A, Solvay
Yes, Roche Is Planning Those Job Cuts
Pharmalot
Friday, September 3, 2010 - 8:16am
tags:
layoffs, Roche
Future of Genzyme / Isis Pharma's Cholesterol Drug Still Up in the Air
Seeking Alpha
Friday, September 3, 2010 - 8:10am
tags:
Genzyme, Isis Pharmaceuticals, mipomersen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.